参考文献

[1]王陇德.健康管理师[M].2版.北京：人民卫生出版社，2019.

[2]American Association of Cardiovascular and Pulmonary Rehabilitation.American guidelines for cardiac Rehabilitation and Secondary Prevention Programs(Fifth Edition)[M].Champaign:Human Kinetics,2017.

[3]ZHANG Z Z,BIEG J,MORI M,et al.A way forward for cancer prevention therapy:personalized risk assessment[J].Oncotarget,2019,10(64):6898-6912.

[4]ANDERSON E L,OMENN G S,TURNHAM P.Improving health risk assessment as a basis for public health decisions in the21st century[J].Risk Anal,2020,40(S1):2272-2299.

[5]DARMON A,DUCROCQ G.Ischaemic and bleeding risk assessment after myocardial infarction:combination is the key[J].Heart,2019,105(15):1138-1139.

[6]PREVENTIVE SERVICES TASK FORCE US,CUKKY S T,KRIST A H,et al.Risk assessment for cardiovascular disease with nontraditional risk factors:us preventive services task force recommendation statement[J].JAMA,2018,320(3):272-280.

[7]PLETCHER M J,MORAN A E.Cardiovascular risk assessment[J].Med Clin North Am,2017,101(4):673-688.

[8]COLLINS G S,DE GROOT J A,DUTTON S,et al.External validation of multivariable prediction models:a systematic review of methodological conduct and reporting[J].BMC Med Res Methodol,2014,14:40.

[9]陈宗涛，聂聪.健康风险评估管理[M].重庆：重庆出版社，2024：26-27.